Literature DB >> 1871043

Inactivation kinetics of enzyme pharmaceuticals in aqueous solution.

S Yoshioka1, K Izutsu, Y Aso, Y Takeda.   

Abstract

The kinetics of enzyme inactivation in aqueous solution of neutral pH were studied for alpha-chymotrypsin, bromelain, and kallikrein. Inactivation of alpha-chymotrypsin and bromelain followed simple first-order kinetics, and the rate constant obtained conformed to the Arrhenius relationship. Kallikrein, however, presented more complicated kinetics of inactivation, which could be described by a kinetic expression combining a reversible and an irreversible pathway. Nonlinear regression analysis suggested that the rate constants conform reasonably well to the Arrhenius relationship. The results suggest that inactivation of enzymes in aqueous solution can be modeled even if the profile is complicated and that the inactivation rates can be predicted based on the relationship between the parameter estimates and temperature.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1871043     DOI: 10.1023/a:1015899011324

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  14 in total

1.  Thermal stability of freeze-dried mammalian interferons. Analysis of freeze-drying conditions and accelerated storage tests for murine interferon.

Authors:  P Jameson; D Greiff; S E Grossberg
Journal:  Cryobiology       Date:  1979-08       Impact factor: 2.487

2.  Potency stability of recombinant (Serine-17) human interferon-beta.

Authors:  J Geigert; D L Ziegler; B M Panschar; A A Creasey; C R Vitt
Journal:  J Interferon Res       Date:  1987-04

3.  High-performance liquid chromatographic method for the determination of the esterase activity of subtilisin and kallikrein.

Authors:  P Pietta; P Mauri; M Pace
Journal:  J Chromatogr       Date:  1988-06-10

Review 4.  Alternative delivery systems for peptides and proteins as drugs.

Authors:  D A Eppstein; J P Longenecker
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  1988       Impact factor: 4.889

5.  Overview of the stability and handling of recombinant protein drugs.

Authors:  J Geigert
Journal:  J Parenter Sci Technol       Date:  1989 Sep-Oct

6.  Estimation of the stability of dry horse serum cholinesterase by means of an accelerated storage test.

Authors:  B R Cole; L Leadbeater
Journal:  J Pharm Pharmacol       Date:  1968-01       Impact factor: 3.765

7.  The mechanisms of irreversible enzyme inactivation at 100C.

Authors:  T J Ahern; A M Klibanov
Journal:  Science       Date:  1985-06-14       Impact factor: 47.728

8.  Kinetics of digestive enzyme stability in the solid state. II Quantitative prediction of enzyme inactivation.

Authors:  M Sugiura; M Kurobe; S Tamura; S Ikeda
Journal:  Chem Pharm Bull (Tokyo)       Date:  1981-07       Impact factor: 1.645

9.  [Studies on the quality of enzyme preparations (III) Pharmaceutical studies on commercially available bromelain preparation].

Authors:  T Tanimoto; H Fukuda; J Kawamura
Journal:  Eisei Shikenjo Hokoku       Date:  1982

10.  Dry thermal inactivation of trypsin and ribonuclease.

Authors:  P F Mullaney
Journal:  Nature       Date:  1966-05-28       Impact factor: 49.962

View more
  8 in total

1.  Stability of beta-galactosidase, a model protein drug, is related to water mobility as measured by 17O nuclear magnetic resonance (NMR).

Authors:  S Yoshioka; Y Aso; K Izutsu; T Terao
Journal:  Pharm Res       Date:  1993-01       Impact factor: 4.200

2.  Is stability prediction possible for protein drugs? Denaturation kinetics of beta-galactosidase in solution.

Authors:  S Yoshioka; Y Aso; K Izutsu; S Kojima
Journal:  Pharm Res       Date:  1994-12       Impact factor: 4.200

3.  Inhibition of succinimide formation in aqueous Zn-rHirudin suspensions.

Authors:  U Gietz; T Arvinte; R Alder; H P Merkle
Journal:  Pharm Res       Date:  1999-10       Impact factor: 4.200

4.  Utilizing Simple Biochemical Measurements to Predict Lifetime Output of Biocatalysts in Continuous Isothermal Processes.

Authors:  Thomas A Rogers; Andreas S Bommarius
Journal:  Chem Eng Sci       Date:  2010-03-15       Impact factor: 4.311

5.  Targeted delivery of tissue plasminogen activator by binding to silica-coated magnetic nanoparticle.

Authors:  Jyh-Ping Chen; Pei-Ching Yang; Yunn-Hwa Ma; Su-Ju Tu; Yu-Jen Lu
Journal:  Int J Nanomedicine       Date:  2012-09-27

6.  Tacorin, an extract from Ananas comosus stem, stimulates wound healing by modulating the expression of tumor necrosis factor α, transforming growth factor β and matrix metalloproteinase 2.

Authors:  Puji Rahayu; Lia Agustina; Raymond R Tjandrawinata
Journal:  FEBS Open Bio       Date:  2017-06-09       Impact factor: 2.693

7.  Minimal Pathway for the Regeneration of Redox Cofactors.

Authors:  Michele Partipilo; Eleanor J Ewins; Jacopo Frallicciardi; Tom Robinson; Bert Poolman; Dirk Jan Slotboom
Journal:  JACS Au       Date:  2021-11-12

8.  Properties and therapeutic application of bromelain: a review.

Authors:  Rajendra Pavan; Sapna Jain; Ajay Kumar
Journal:  Biotechnol Res Int       Date:  2012-12-10
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.